AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Washingtonpost

Published November 12, 2026 · Updated November 13, 2026

Say cheese! New Congress members pose for class photo. - The Washington Post

Read the full story at Washingtonpost

Ibogaine W. Bryan Hubbard watch as President Donald Trump in April announced support for psychedelics research. (Allison Robbert/For The.

Post on X

Share this story

Surfaced by this Google Alert

Ibogaine